Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 390301 - 390320 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Saudi Arabia | (L01FA01) rituximab | Ruxience 500 mg per 50 ml | 1 Vial, 50ml, 10 mg/ml, Intravenous use, Concentrate for solution for infusion, 10mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell; Arthritis, Rheumatoid; Microscopic Polyangiitis; Pemphigus | PfizerEuropeMAEEIG / PfizerManufacturingBelgiumN.V. |
| Saudi Arabia | (L01FD01) trastuzumab | HERZUMA | 1 Vial, 50ml, 440 mg, Intravenous use, Powder for concentrate for solution for infusion, 440mg , Vial, Powder for concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | JazeeraPharmaceuticalIndustries(JPI) / CELLTRIONINC |
| Saudi Arabia | (L01FD01) trastuzumab | HERZUMA 150MG VIAL | 1 Vial, 150 mg, Intravenous use, Powder for concentrate for solution for infusion, 150mg , Vial, Powder for concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | JazeeraPharmaceuticalIndustries(JPI) / CELLTRIONINC |
| Saudi Arabia | (L01FD01) trastuzumab | Kanjinti | 1 Vial, 150 mg, Intravenous use, Powder for concentrate for solution for infusion, 150mg , Vial, Powder for concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | AmgenEuropeBV / AMGENTECHNOLOGY |
| Saudi Arabia | (L01FD01) trastuzumab | Kanjinti | 1 Vial, 420 mg, Intravenous use, Powder for concentrate for solution for infusion, 420mg , Vial, Powder for concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | AMGENEUROPEB.V. / AMGENTECHNOLOGY |
| Saudi Arabia | (L01FD03) trastuzumab emtansine | KADCYLA 100 mg powder for concentrate for solution for infusion | 1 Vial, 100 mg, Intravenous use, Powder for concentrate for solution for infusion, 100mg , Vial, Powder for concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | ROCHE / PatheonManufacturingServicesLLC |
| Saudi Arabia | (L01FD03) trastuzumab emtansine | KADCYLA 160 mg powder for concentrate for solution for infusion | 1 Vial, 160 mg, Intravenous use, Powder for concentrate for solution for infusion, 160mg , Vial, Powder for concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | ROCHE / PatheonManufacturingServicesLLC |
| Saudi Arabia | (L01FD04) trastuzumab deruxtecan | Enhertu | 1 Vial, 100 mg, Intravenous use, Powder for concentrate for solution for infusion, 100mg , Vial, Powder for concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | AstraZeneca / BAXTERONCOLOGYGmbH |
| Saudi Arabia | (L01FE02) panitumumab | VECTIBIX 20MG/ML CONC. SOLUTION FOR INFUSION | 1 Vial, 5ml, 20 mg/ml, Intravenous use, Concentrate for solution for infusion, 20mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AMGENEUROPEB.V. / AMGENMANUFACTURINGLIMITED |
| Saudi Arabia | (L01FF01) nivolumab | OPDIVO 10 mg/ml solution for injection | 1 Vial, 4ml, 10 mg/ml, Intravenous use, Solution for injection, 10mg/ml , Vial, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
Melanoma; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Urologic Neoplasms; Mesothelioma; Colorectal Neoplasms | BRISTOL-MYERSSQUIBB / BRISTOL-MYERSSQUIBB |
| Saudi Arabia | (L01FF01) nivolumab | OPDIVO 10 mg/ml solution for injection | 1 Vial, 10ml, 10 mg/ml, Intravenous use, Solution for injection, 10mg/ml , Vial, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
Melanoma; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Urologic Neoplasms; Mesothelioma; Colorectal Neoplasms | BRISTOL-MYERSSQUIBB / BRISTOL-MYERSSQUIBB |
| Saudi Arabia | (L01FF02) pembrolizumab | KEYTRUDA 25 mg/ml Concentrate For Solution For Infusion | 1 Vial, 4ml, 25 mg/ml, Intravenous use, Concentrate for solution for infusion, 25mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Melanoma; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Urologic Neoplasms; Endometrial Neoplasms | MERCKSHARP&DOHME / MSDINTERNATIONALGMBHT/AMSD |
| Saudi Arabia | (L01FF05) atezolizumab | TECENTRIQ 60 mg/ml Concentrate For Solution For Infusion | 1 Vial, 20ml, 60 mg/ml, Intravenous use, Injection, 60mg/ml , Vial, Injection | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | ROCHE / ROCHEDIAGNOSTICS |
| Saudi Arabia | (L01FG01) bevacizumab | AVASTIN 100 solution for infusion | 1 Vial, 4ml, 25 mg/ml, Intravenous use, Concentrate for solution for infusion, 25mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung; Breast Neoplasms; Ovarian Neoplasms; Colorectal Neoplasms; Carcinoma, Renal Cell | ROCHE&COLTD / ROCHEDIAGNOSTICS |
| Saudi Arabia | (L01FG01) bevacizumab | AVASTIN 400 solution for infusion | 1 Vial, 16ml, 25 mg/ml, Intravenous use, Concentrate for solution for infusion, 25mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung; Breast Neoplasms; Ovarian Neoplasms; Colorectal Neoplasms; Carcinoma, Renal Cell | ROCHE&COLTD / ROCHEDIAGNOSTICS |
| Saudi Arabia | (L01FG01) bevacizumab | Zirabev | 1 Vial, 4ml, 25 mg/ml, Intravenous use, Concentrate for solution for infusion, 25mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms | PfizerEuropeMAEEIG / PFIZER |
| Saudi Arabia | (L01FG01) bevacizumab | Zirabev | 1 Vial, 16ml, 25 mg/ml, Intravenous use, Concentrate for solution for infusion, 25mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms | PfizerEuropeMAEEIG / PFIZER |
| Saudi Arabia | (L01FX04) ipilimumab | YERVOY 5 mg/ml intravenous infusion | 1 Vial, 10ml, 5 mg/ml, Intravenous use, Intravenous infusion, 5mg/ml , Vial, Intravenous infusion | Retail price without vat |
$0-0 |
$0-0 |
Melanoma; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Mesothelioma, Malignant; Colorectal Neoplasms | BRISTOL-MYERSSQUIBB / BAXTERPHARMACEUTICALSOLUTIONLLC |
| Saudi Arabia | (L01FX17) sacituzumab govitecan | Trodelvy | 1 Vial, 180 mg, Intravenous use, Powder for concentrate for solution for infusion, 180mg , Vial, Powder for concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms; Triple Negative Breast Neoplasms | GILEADSCIENCESLIMITED(CORK) / BSPPHARMACEUTICALS |
| Saudi Arabia | (L01FX18) amivantamab | Rybrevant 350 mg per 7 ml | 1 Vial, 7ml, 50 mg/ml, Intravenous use, Concentrate for solution for infusion, 50mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | Janssen-CilagInternationalNV / CilagAG,Schaffhausen,Switzerland |
Pages
